In February, AstraZeneca and Daiichi Sankyo teased the results of their pivotal trial of Enhertu in HER2-low breast cancer, and, at ASCO, they finally revealed the data – with the numbers every ...

NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”.

The Food and Drug Administration (FDA) has approved Enhertu ® (fam-trastuzumab deruxtecan-nxki) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...

In the market for a deal on a new car? If you can stretch to £300 per month, you’ll have a veritable treasure trove of finance deals to pick from. The sheer number of models that fall into this range ...

The Royal Enfield Bullet 350 holds a special place in the segment due to its retro design, rich heritage, and reliability. The Bullet 350 is built on an all-new chassis to contain RE's new J ...

Found the MG ZS of your dreams? Now you want to know all about it! With the help of Parkers, you can find out all of the key specs about the MG ZS from fuel efficiency in MPG and top speed in MPH, to ...